retatrutide dosing phase 2 trial Guide: 1-12 mg Weekly Triple Agonist (2026) dosing cagrilintide with retatrutide dosage

[END CALLOUT BOX] GLP2 Pharmacokinetics & Metabolism Absorption & Distribution Following subcutaneous administration, GLP2 exhibits favorable pharmacokinetic properties enabling once-weekly dosing: Mean absolute bioavailability of approximately 80% after subcutaneous injection Time to maximum plasma concentration (Tmax) ranges from 8 to 72 hours Steady-state plasma concentrations achieved after 4 weeks of once-weekly dosing Mean steady-state volume of distribution approximately 10.3 L, indicating limited tissue distribution The high plasma protein binding to albumin (99%) results from the C20 fatty diacid modification, which provides prolonged systemic exposure and enables sustained therapeutic effects between weekly doses

Replaces 16 supplements 95% felt more energy

The slight difference in results is not clinically significant, and individual results vary based on adherence to diet and exercise recommendations

Snack (195 calories) Lunch (347 calories) 1 large pear P.M

When Dr

The Competency Question The pushback youll hear: Thats outside your scope stick to mental health. But scope of practice is defined by competency and training , not just specialty tradition